Key result
Benchside testing of drug-eluting stents using scanning electron microscopy and microcomputed tomography helps identify coating irregularities and explains potential differences in clinical performance.
Benchside evaluation of drug-eluting stents provides critical data on coating irregularities and geometry that may explain differences in clinical performance.
Benchside stent imaging may inform device selection; leaves open prospective validation of coating metrics against clinical outcomes.
The surface of drug-eluting stents (DES) may partly contribute to some DES-related problems and betweenDES differences in clinical performance. This article sheds light on benchside testing of DES that permits the identification, classification and quantification of various coating irregularities, both after gentle stent deployment and high-pressure postdilatation. In addition, we discuss the value of combining surface assessment with scanning electron microscopy and examinations of DES geometry with microcomputed tomography. This article gives an overview of independent benchside research on commercially available DES. Such data are generally difficult to obtain, but may help to generate theories that explain potential differences in clinical performance between DES. These benchside studies should ideally be performed by multidisciplinary research teams embedded in high-level research institutes, to ensure a prompt reaction to shifting demands, as they may soon be required considering upcoming novel DES concepts.
No takes yet. Share an insight, caveat, or question.
Basalus et al. (2010) reported a review. Benchside testing of drug-eluting stents was evaluated. Benchside testing of drug-eluting stents using scanning electron microscopy and microcomputed tomography helps identify coating irregularities and explains potential differences in clinical performance.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: